472 related articles for article (PubMed ID: 18805512)
1. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress.
Aggarwal M; Sommers JA; Shoemaker RH; Brosh RM
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1525-30. PubMed ID: 21220316
[TBL] [Abstract][Full Text] [Related]
3. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
Tomicic MT; Christmann M; Kaina B
Cancer Res; 2005 Oct; 65(19):8920-6. PubMed ID: 16204064
[TBL] [Abstract][Full Text] [Related]
4. Werner's syndrome lymphoblastoid cells are hypersensitive to topoisomerase II inhibitors in the G2 phase of the cell cycle.
Pichierri P; Franchitto A; Mosesso P; Proietti de Santis L; Balajee AS; Palitti F
Mutat Res; 2000 Mar; 459(2):123-33. PubMed ID: 10725663
[TBL] [Abstract][Full Text] [Related]
5. Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin.
Huang X; Okafuji M; Traganos F; Luther E; Holden E; Darzynkiewicz Z
Cytometry A; 2004 Apr; 58(2):99-110. PubMed ID: 15057963
[TBL] [Abstract][Full Text] [Related]
6. Werner syndrome protein prevents DNA breaks upon chromatin structure alteration.
Turaga RV; Massip L; Chavez A; Johnson FB; Lebel M
Aging Cell; 2007 Aug; 6(4):471-81. PubMed ID: 17521388
[TBL] [Abstract][Full Text] [Related]
7. Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.
Godard T; Deslandes E; Sichel F; Poul JM; Gauduchon P
Mutat Res; 2002 Sep; 520(1-2):47-56. PubMed ID: 12297143
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
Zhao H; Traganos F; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
[TBL] [Abstract][Full Text] [Related]
9. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
[TBL] [Abstract][Full Text] [Related]
11. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
12. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment.
Chen S; Gomez SP; McCarley D; Mainwaring MG
Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828
[TBL] [Abstract][Full Text] [Related]
13. The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage.
Mao FJ; Sidorova JM; Lauper JM; Emond MJ; Monnat RJ
Cancer Res; 2010 Aug; 70(16):6548-55. PubMed ID: 20663905
[TBL] [Abstract][Full Text] [Related]
14. Perturbed replication induced genome wide or at common fragile sites is differently managed in the absence of WRN.
Murfuni I; De Santis A; Federico M; Bignami M; Pichierri P; Franchitto A
Carcinogenesis; 2012 Sep; 33(9):1655-63. PubMed ID: 22689923
[TBL] [Abstract][Full Text] [Related]
15. WRN is required for ATM activation and the S-phase checkpoint in response to interstrand cross-link-induced DNA double-strand breaks.
Cheng WH; Muftic D; Muftuoglu M; Dawut L; Morris C; Helleday T; Shiloh Y; Bohr VA
Mol Biol Cell; 2008 Sep; 19(9):3923-33. PubMed ID: 18596239
[TBL] [Abstract][Full Text] [Related]
16. Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons.
Huelsenbeck SC; Schorr A; Roos WP; Huelsenbeck J; Henninger C; Kaina B; Fritz G
J Biol Chem; 2012 Nov; 287(46):38590-9. PubMed ID: 23012366
[TBL] [Abstract][Full Text] [Related]
17. Assessment of DNA double-strand breaks and gammaH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone.
Smart DJ; Halicka HD; Schmuck G; Traganos F; Darzynkiewicz Z; Williams GM
Mutat Res; 2008 May; 641(1-2):43-7. PubMed ID: 18423498
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
[TBL] [Abstract][Full Text] [Related]
19. Werner syndrome helicase has a critical role in DNA damage responses in the absence of a functional fanconi anemia pathway.
Aggarwal M; Banerjee T; Sommers JA; Iannascoli C; Pichierri P; Shoemaker RH; Brosh RM
Cancer Res; 2013 Sep; 73(17):5497-507. PubMed ID: 23867477
[TBL] [Abstract][Full Text] [Related]
20. Immunodetection of human topoisomerase I-DNA covalent complexes.
Patel AG; Flatten KS; Peterson KL; Beito TG; Schneider PA; Perkins AL; Harki DA; Kaufmann SH
Nucleic Acids Res; 2016 Apr; 44(6):2816-26. PubMed ID: 26917015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]